The production of a new extracellular putative long-chain saturated polyester by smooth variants of Mycobacterium vaccae interferes with Th1-cytokine production

Antonie van Leeuwenhoek, International Journal of General and Molecular Microbiology

Volumn 90, Issue 1, 2006, Pages 93-108

  Rodríguez Güell, Elisabeth ^a   Agustí, Gemma ^a   Corominas, Mercè ^b   Cardona, Pere Joan ^c   Casals, Isidre ^d   Parella, Teodor ^a   Sempere, Marco Antonio ^e   Luquin, Marina ^a   Julián, Esther ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c Fundació Institut   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e HOSPITAL COSTA DEL SOL   (Spain)

Author keywords

Colony morphology; Exopolymer; IFN ; Long chain saturated polyester; Mycobacterium vaccae

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLYCOLIPID; IMMUNOMODULATING AGENT; INTERLEUKIN 12P40; LIPID; MANNOSIDE; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; POLYESTER; TREHALOSEDIMYCOLIC ACID DERIVATIVE; TREHALOSEMOMOMYCOLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

BACTERIUM; COLONY STRUCTURE; EXOPOLYMER; MICROBIAL COMMUNITY; MICROMORPHOLOGY;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM COLONY; CELL COMPOSITION; CELL PROLIFERATION; CELL WALL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNIZATION; IMMUNOMODULATION; MICROMORPHOLOGY; MORPHOTYPE; MOUSE; MYCOBACTERIUM VACCAE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TEMPERATURE MEASUREMENT; TH1 CELL;

ANIMALS; CELL PROLIFERATION; CELL WALL; CYTOKINES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLYCOLIPIDS; IMMUNOLOGIC FACTORS; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-4; LIPIDS; MICE; MICE, INBRED BALB C; MYCOBACTERIUM; POLYESTERS; SPLEEN; TH1 CELLS;

MYCOBACTERIUM VACCAE;

EID: 33745941137     PISSN: 00036072     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10482-006-9062-1     Document Type: Article

References (49)

1. Abbot N.C., Beck J.S., Feval F., Weiss F., Mobayen M.H., Ghazi-Saidi K., Dowlati Y., Velayati A.A., Stanford J.L. (2002) Immunotherapy with Mycobacterium vaccae and pe ripheral blood flow in long-treated leprosy patients, a randomised, placebo-controlled trial. Eur. J. Vasc. Endovasc. Surg. 24: 202-208
2. Abou-Zeid C., Gares M.P., Inwald J.,Janssen R., Zhang Y., Young D.B., Hetzel C., Lamb J.R., Baldwin S.L., Orme I.M., Yeremeev V., Nikonenko B.V., Apt A.S. (1997) Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect. Immun. 65: 1856-1862
3. Arkwright P.D., David T.J. (2001) Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J. Allergy Clin. Immunol. 107: 531-534
4. Balagon M.V., Walsh D.S., Tan P.L., Cellona R.V., Abalos R.M., Tan E.V., Fajardo T.T., Watson J.D., Walsh G.P. (2000) Improvement in psoriasis after intradermal administration of heat-killed Mycobacterium vaccae. Int. J. Dermatol. 39: 51-58
5. Balagon M.V., Tan P.L., Prestidge R., Cellona R.V., Abalos R.M., Tan E.V., Walsh G.P., Watson J.D., Walsh D.S. (2001) Improvement in psoriasis after intradermal administration of delipidated, deglycolipidated Mycobacterium vaccae (PVAC): Results of an open-label trial. Clin. Exp. Dermatol. 26: 233-241
6. Barrow W.W., Brennan P.J. (1982) Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens. J. Bacteriol. 150:381-384
7. Belisle J.T., Brennan P.J. (1989) Chemical basis of rough and smooth variation in mycobacteria. J. Bacteriol. 171: 3465-3470
8. Boenickse R., Juhasz E. (1964) Boeschreibung der neuen Species Mycobacterium vaccae n. sp. Zbl. Bakt. Abt. I, Orig A. 192: 133-135
9. Camporota L., Corkhill A., Long H., Lordan J., Stanciu L., Tuckwell N., Cross A., Stanford J.L., Rook G.A., Holgate S.T., Djukanovic R. (2003) The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. Eur. Respir. J. 21:287-293
10. Cermak S.C., Isbell T.A. (2003) Synthesis and physical properties of estolide-based functional fluids. Ind. Crops Products. 18: 183-196
11. Chadwick M.V. (1981) Mycobacteria - (Monographs in Medical laboratory science series). Wright-PSG, London
12. Chambaz E.M., Horning E.C. (1969) Conversion of steroids to trimethylsilyl derivatives for gas phase analytical studies: Reactions of silylating reagents. Anal. Biochem. 30:7-24
13. da Silva T.R., de Freitas J.R., Silva Q.C., Figueira C.P., Roxo E., Leao S.C., de Freitas L.A., Veras P.S. (2002) Virulent Mycobacterium fortuitum restricts NO production by a gamma interferon-activated J774 cell line and phagosome-lysosome fusion. Infect. Immun. 70: 5628-5634
14. Daffé M., Draper P. (1998) The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 39:131-203
15. Etienne G., Villeneuve C., Billman-Jacobe H., Astarie-Dequeker C., Dupont M.A., Daffé M. (2002) The impact of the absence of glycopeptidolipids on the ultrastructure, cell surface and cell wall properties, and phagocytosis of Mycobacterium smegmatis. Microbiology 148: 3089-3100
16. Friebolin H. (1991) Basic One- and Two-dimensional NMR Spectroscopy. VCH, Weinheim
17. Hadley E.A., Smillie F.I., Turner M.A., Custovic A., Wookcock A., Arkwright P.D. (2005) Effect of Mycobacterium vaccae on cytokine responses in children with atopic dermatitis. Clin. Exp. Immunol. 140: 101-108
18. Hölscher C. (2004) The power of combinatorial immunology: IL-12 and IL-12 related dimeric cytokines in infectious diseases. Med. Microbiol. Immunol. 193: 1-17
19. Hrouda D., Baban B., Dunsmuir W.D., Kirby R.S., Dalgleish A.G. (1998) Immunotherapy of advanced prostate cancer: A phase I/II trial using Mycobacterium vaccae (SRL172). Br. J. Urol. 82: 568-573
20. Janssen R., Kruisselbrink A., Hoogteijling L., Lamb J.R., Young D.B., Thole J.E. (2001) Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model. Immunology 102: 441-449
21. Knothe G., Nelsen T.C. (1998) Evaluation of the 13C NMR signals of saturated carbons in some long-chain compounds. J. Chem. Soc. Perkin Trans. 29:2019-2026
22. Luquin M., Ausina V., Lopez-Calahorra F., Belda F., Garcia-Barceló M., Celma C., Prats G. (1991) Evaluation of practical chromatographic procedures for identification of clinical isolates of mycobacteria. J. Clin. Microbiol. 29:120-130
23. Martinez A., Torello S., Kolter R. (1999) Sliding motility in mycobacteria. J. Bacteriol. 181:7331-7338
24. Mayo R.E., Stanford J.L. (2000) Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-1997. Trans. R. Soc. Trop. Med. Hyg. 94:563-568
25. Mendes R., O'Brien M.E.R., Mitra A., Norton A., Gregory R.K., Padhani A.R., Bromelow K.V., Winkley A.R., Ashley S., Smith I.E., Souberbielle B.E. (2002) Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma. Br. J. Cancer 86: 336-341
26. Moehring J.M., Solotorovsky M.R. (1965) Relationship of colonial morphology to virulence for chickens of Mycobacterium avium and the nonphotochromogens. Am. Rev. Respir. Dis. 92: 704-713
27. Muñoz M., Raynaud C., Lanéelle M.A., Julián E., Lopez Marín L.M., Silve G., Ausina V., Daffé M., Luquin M. (1998) Seroreactive species-specific lipooligosaccharides of Mycobacterium mucogenicum sp. nov. (formerly Mycobacterium chelonae -like organisms): Identification and chemical characterization. Microbiology 144: 137-148
28. O'Brien M.E., Saini A., Smith I.E., Webb A., Gregory K., Mendes R., Ryan C., Priest K., Bromelow K.V., Palmer R.D., Tuckwell N., Kennard D.A., Souberbielle B.E. (2000) A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma. Br. J. Cancer 83: 853-857
29. O'Brien M.E., Anderson H., Kaukel E., O'Byrne K., Pawlicki M., Von Pawel J., Reck M., SR-ON-12 Study Group. (2004) SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: Phase III results. Ann. Oncol. 15: 906-914
30. Peláez M., Orellana C., Marques A., Busquets M., Guerrero A., Manresa A. (2003) Natural estolides produced by Pseudomonas sp 42a2 grown on oleic acid: Production and characterization. J. Am. Oil Chem. Soc. 80:859-866
31. Pym A.S., Brodin P., Brosch R., Huerre M., Cole S.T. (2002) Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol. Microbiol. 46: 709-717
32. Recht J., Martinez A., Torello S., Kolter R. (2000) Genetic analysis of sliding motility in Mycobacterium smegmatis. J. Bacteriol. 182: 4348-4351
33. Reddy V.M., Luna-Herrera J., Gangadharam P.R.J. (1996) Pathobiological significance of colony morphology in Mycobacterium avium complex. Microb. Pathog. 21: 97-109
34. Roach D.R., Martin E., Bean A.G., Rennick D.M., Biscoe H., Britton W.J. (2001) Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand. J. Immunol. 54: 163-170
35. Rotzsche H. (1991) Gas chromatographic analysis of fatty acid salts. J. Chromat. A. 552: 281-288
36. 13C NMR of virgin olive oil. An overview. Magn. Reson. Chem. 35:S133-S145
37. Schaefer W.B., Davis C.L., Cohn M.L. (1970) Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice. Am. Rev. Respir. Dis. 102: 499-506
38. Shirtcliffe P.M., Eastophe S.E., Cheng S., Weatherall M., Tan P.L., Le gros G., Beasley R. (2001) The Effect of Delipidated Deglycolipidated (DDMV) and Heat-killed Mycobacterium vaccae in Asthma. Am. J. Respir. Crit. Care Med. 163:1410-1414
39. Shirtcliffe P.M., Goldkorn A., Weatherall M., Tan P.L., Beasley R. (2003) Pilot study of the safety and effect of intranasal delipidated acid-treated Mycobacterium vaccae in adult asthma. Respirology 8:497-503
40. Skinner M.A., Prestidge R., Yuan S., Strabala T.J., Tan P.L. (2001) The ability of heat-killed Mycobacterium vaccae to stimulate a cytotoxic T-cell response to an unrelated protein is associated with a 65 kDa heat-shock protein. Immunology 2: 225-233
41. Skinner M.A., Yuan S., Prestidge R., Chuk D., Watson J.D., Tan P.L.J. (1997) Immunization with heat-killed Mycobacterium vaccae stimulates CD81 cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis. Infect. Immun. 65:4525-4530
42. Stanford J.L., Paul R.C. (1973) A preliminary report on some studies of environmental mycobacteria. Ann. Soc. Belg. Med. Trop. 53: 389-393
43. Stanford J., Stanford C., Grange J. (2004) Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis. Front. Biosci. 9: 1701-1719
44. Thornton A.M., Shevach E.M. (1998) CD4+CD25+ immunoregulatory T cells supress polyclonal T cell activation in vitro by inhibiting interleukin-2 production. J. Exp. Med. 188: 287-296
45. Van Boxtel R.M., Lambrecht R.S., Collins M.T. (1990) Effects of colonial morphology and tween 80 on antimicrobial susceptibility of Mycobacterium paratuberculosis. Antimicrob. Agents Chemother. 34: 2300-2303
46. Vestal A.L., Kubica G.P. (1966) Differential colonial characteristics of mycobacteria on Middlebrook and Cohn 7H10 agar-base medium. Am. Rev. Respir. Dis. 94: 247-252
47. Wang C.C., Rook G.A.W. (1998) Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology 93: 307-313
48. Wayne L.G., Kubica G.P. (1986) The mycobacteria. In: Holt J.G., Sneath P.H., Mair N.S., Sharpe M.E. (eds) Bergey's Manual of Systematic Bacteriology, Vol. 2. Williams & Wilkins, Baltimore, MD, pp 1435-1457
49. Zuany-Amorim C., Manlius C., Trifilieff C., Brunet L.R., Rook G., Bowen G., Pay G., and Walker C. (2002) Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J. Immunol. 169:1492-1499